Modulation of in vivo IgG crystallization in the secretory pathway by heavy chain isotype class switching and N-linked glycosylation |
| |
Authors: | Haruki Hasegawa Carla ForteIrene Barber Shanon TurnbaughJanelle Stoops Min ShenAi Ching Lim |
| |
Affiliation: | Department of Therapeutic Discovery, Amgen Inc., 1201 Amgen Court West, Seattle, WA 98119, USA |
| |
Abstract: | Crystalline bodies (CBs) can develop in the endoplasmic reticulum (ER) of antibody-producing cells. Although this phenotype is often reported in association with plasma cell dyscrasias and other hematological disorders, the details of CB biogenesis and CB's roles in pathophysiology remain poorly understood. Using an imaging-based screening method, we identified a secretion-competent human IgG2/λ clone that develops spindle-shaped intracellular crystals in transiently-transfected HEK293 cells upon Brefeldin A treatment. When stably overexpressed from CHO cells, the IgG2/λ clone spontaneously produced spindle-shaped CBs in the ER. Some CBs were released to the extracellular space while remaining enclosed by the membranes of secretory pathway origin. Structural modeling on the variable-region did not uncover prominent surface characteristics such as charge clusters. In contrast, alterations to the constant domain-encoded properties revealed their modulatory roles in CB-inducing propensities and CB morphology. For example, deletion of the entire Fc domain changed the morphology of CBs into thin filaments. Elimination of an N-linked glycan by a N297A mutation promoted Russell body biogenesis accompanied by marked reduction in IgG secretion. Isotype class switching from the original IgG2 to IgG1 and IgG4 changed the crystal morphology from spindle-shaped to long needle and acicular shaped, respectively. The IgG3 version, in contrast, suppressed the CB formation. Either the HC or LC alone or the Fc-domain alone did not trigger CB biogenesis. An IgG's in vivo crystal morphology and crystallization propensity can thus be modulated by the properties genetically and biochemically encoded in the HC constant region. |
| |
Keywords: | BFA, Brefeldin A CB, crystalline body CDR, complementarity-determining region CH1, heavy chain constant domain-1 CH2, heavy chain constant domain-2 CH3, heavy chain constant domain-3 CL, light chain constant domain CHO, Chinese hamster ovary DIC, differential interference contrast ER, endoplasmic reticulum ERGIC, ER-Golgi intermediate compartment Fab, antigen binding fragment Fc, crystallizable fragment GAPDH, glyceraldehyde 3-phosphate dehydrogenase HC, heavy chain HEK, human embryonic kidney IgG, immunoglobulin G LC, light chain RB, Russell body VH, heavy chain variable domain VL, light chain variable domain V-region, variable region |
本文献已被 ScienceDirect 等数据库收录! |
|